Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
about
Overweight, obesity, and elevated serum cystatin C levels in adults in the United StatesCystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyEstimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKDCystatin C and risk of heart failure in the Physicians' Health Study (PHS)Biomarkers in chronic kidney disease, from kidney function to kidney damageCystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients?Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study.Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians.Screening for chronic kidney disease in HIV-infected patients.Diminished renal function and the incidence of heart failure.Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosisKidney function and cognitive health in older adults: the Cardiovascular Health Study.Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cellsCystatin C, a novel indicator of renal function, reflects severity of cerebral microbleedsCystatin C and sudden cardiac death risk in the elderly.Rapid kidney function decline and mortality risk in older adults.Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients.Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula.Association of cystatin C with adverse outcomes.Is renal function associated with early age-related macular degeneration?Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health studyEpidemiology of chronic kidney disease in heart failure.Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul StudyAssociations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyEstimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population.The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population.Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women.Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women.Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure.Albuminuria and the risk of incident stroke and stroke types in older adults.Cystatin C identifies chronic kidney disease patients at higher risk for complications.
P2860
Q24607254-7D99B163-1F22-44E5-984B-6A4DBD4EE081Q24635177-CBB1306E-4C45-41CC-910B-39F584830A0BQ24652643-99183854-E01F-41D3-BE8E-ACCFE9F3EB38Q24685074-2C9DB11A-2E91-451E-80D0-65D69C0EE768Q28087304-48807D4B-12C9-40D7-B321-CB96C5F3AD1DQ28534470-8DC9FA15-6785-4D09-8609-74CE32FB9775Q33276760-1107E43A-D799-41C6-963C-BD1B6E335D06Q33297377-1ABA87C5-9FE8-42EA-B2BA-066567FDF70BQ33402590-8C874D17-5F43-497F-9998-85A38CDFCF24Q33407103-477F97E5-345B-45E8-A7AD-4F96CC9BEBF1Q33562005-93A33C05-7603-4C68-A0DC-6523C12431A0Q33608612-3C75695D-054D-407F-B73D-EF3E545257F3Q33639802-AF97286E-D116-4CBF-87BA-1555AD3FAB2DQ33654021-EFE373CA-45AF-4D75-BDE2-B1CF7536DD52Q33691644-97699E1F-D014-4DA1-A01A-E8DA7DF109F4Q33804430-8D4D9E21-CB6E-407B-85E2-812F9D8D844EQ33806588-68F3BFC7-9AF2-4968-8D6C-A857BC1E1939Q33819382-15963199-3CB0-483F-B794-81B872540E27Q33829301-2A298E13-F89F-4B3B-8D48-815E68B1684FQ33830165-36A6E412-CCF3-41B0-99F7-701CB0DFD989Q33855997-FBFB1EE1-5DB1-48F1-A87D-E0F1AD362252Q33887287-BF1DE4CD-FE06-4293-A247-6A6B092E1A61Q33904523-E7CA8F7E-ADF4-4E95-8499-51B056C9CE76Q33905277-36E10C44-DB60-40CF-A328-C9AE51CAC569Q33925821-B3216F70-F702-4D80-BEDE-BF956A24AD3DQ33932292-0CEAFB39-EACD-4A8B-8BF3-C5D5A126074EQ33953345-ED3B98D4-2208-49CC-9DFB-9E9DC220BA32Q33961569-7CEFAE77-14D9-4936-9A16-C80F8EA88CBDQ33978466-284E3EF3-2C3B-437C-AD40-70091AEE609AQ33988990-41644850-CD82-41F0-B60D-15ECE38CAA74Q34150807-493A8770-020B-42F4-A86C-3C7DBAB1FC46Q34152092-A1E3F1B2-1492-4E11-9A5B-C086839D9FAEQ34210655-85524087-0408-4364-A9A9-F590A4470D26Q34238467-91AD1CA9-E52B-4763-9737-57F756E1A8D4Q34267914-BB1042D5-6F0B-48AD-94D8-C19B2A15086FQ34338563-52B6B657-B603-46A7-87A5-10D7EF47CB2DQ34361219-B887D522-5589-41E1-9CCF-65C12A09A5FFQ34447671-18711502-07B3-4C92-8383-0D585506E5CEQ34455130-452C2DD7-6A91-440C-B3AB-4A769D43C4FAQ34457290-72EAF072-FE8F-49A8-8851-BE3770F6FFE5
P2860
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cystatin C and prognosis for c ...... without chronic kidney disease
@ast
Cystatin C and prognosis for c ...... without chronic kidney disease
@en
Cystatin C and prognosis for c ...... without chronic kidney disease
@nl
type
label
Cystatin C and prognosis for c ...... without chronic kidney disease
@ast
Cystatin C and prognosis for c ...... without chronic kidney disease
@en
Cystatin C and prognosis for c ...... without chronic kidney disease
@nl
prefLabel
Cystatin C and prognosis for c ...... without chronic kidney disease
@ast
Cystatin C and prognosis for c ...... without chronic kidney disease
@en
Cystatin C and prognosis for c ...... without chronic kidney disease
@nl
P2093
P50
P3181
P1476
Cystatin C and prognosis for c ...... without chronic kidney disease
@en
P2093
Anne B Newman
Brian Kestenbaum
Catherine Stehman-Breen
Linda F Fried
Mark J Sarnak
Russell P Tracy
Stephen L Seliger
P304
P3181
P356
10.7326/0003-4819-145-4-200608150-00003
P407
P577
2006-08-15T00:00:00Z